Stocks · News reference

'Activist Barington Pushes Chemed for Strategic Review, Cost Cuts' - Bloomberg

Jul 21, 2026, 12:17 PMBenzinga Newsdesk

https://www.bloomberg.com/news/articles/2026-07-21/activist-barington-pushes-chemed-for-strategic-review-cost-cuts

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 27, 2026, 5:14 PMBenzinga Newsdesk
The Capitol Forum Posts On X "Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and 'Fudged' Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation"
https://x.com/Capitol_Forum/status/2093021234103488646
CHE
BenzingaJul 31, 2026, 4:08 PMBenzinga Newsdesk
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $590
Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $500 to $590.
CHE
BenzingaJul 30, 2026, 5:41 PMBenzinga Newsdesk
RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $548
CHE
SEC EDGARJul 28, 2026, 8:30 PMSEC EDGAR
8-K filing — CHEMED CORP (CHE)
Filed: 2026-07-28 AccNo: 0000019584-26-000018 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
CHE